NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Iopromide

Last Revision: October 31, 2018.

Estimated reading time: 1 minute

CASRN: 73334-07-3

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Intravenous iodinated contrast media are poorly excreted into breastmilk and poorly absorbed orally so they are not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a iodine-containing contrast medium.[1][2][3][4] However, because there is no published experience with iopromide during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Diatrizoate, Iohexol

References

1.
American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2017;Version 10.3:102-3. https://www​.acr.org/~​/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf.
2.
Webb JA, Thomsen HS, Morcos SK et al. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234-40. [PubMed: 15609057]
3.
Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333-40. [PubMed: 18669732]
4.
Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e216. [PubMed: 28937575]

Substance Identification

Substance Name

Iopromide

CAS Registry Number

73334-07-3

Drug Class

  • Breast Feeding
  • Contrast Media
  • Diagnostic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site .

Views

Related information

Similar articles in PubMed

  • Review Ioversol[Drugs and Lactation Database (...]
    Review Ioversol
    . Drugs and Lactation Database (LactMed). 2006
  • Review Ioxilan[Drugs and Lactation Database (...]
    Review Ioxilan
    . Drugs and Lactation Database (LactMed). 2006
  • Review Iodixanol[Drugs and Lactation Database (...]
    Review Iodixanol
    . Drugs and Lactation Database (LactMed). 2006
  • Review Iopamidol[Drugs and Lactation Database (...]
    Review Iopamidol
    . Drugs and Lactation Database (LactMed). 2006
  • Review Iohexol[Drugs and Lactation Database (...]
    Review Iohexol
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...